AZD-5438

• Description:

  A potent and oral inhibitor of CDK1/2/9 with IC50 of 16/6/20 nM, respectively; also inhibits the kinase activity of p25-Cdk5 (IC50=14 nM) and GSK-3β (IC50=17 nM) in vitro.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  371.4566

• Molecular Formula:

  C18H21N5O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  CDK1|CDK2|CDK9

• CAS Number:

  602306-29-6